β-casein variants and atherosclerosis - Claims are premature

Atherosclerosis

Volumn 170, Issue 1, 2003, Pages 11-12

  Mann, Jim ^a   Skeaff, Murray ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CASEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; EDITORIAL; HUMAN; NONHUMAN; PRIORITY JOURNAL; RABBIT; RISK FACTOR;

EID: 0043264141     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00230-2     Document Type: Editorial

References (5)

1. Tailford KA, Berry CL, Thomas AC, Campbell JH. A casein variant in cow's milk is atherogenic. Atherosclerosis 2003:170;13-9.
2. West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF et al. Systems to rate the strength of scientific evidence. Rockville, MD: Agency for Healthcare Research and Quality; 2002 April 2002. Report No.: Evidence Report/Technology Assessment Number 47.
3. Mann J. Discrepancies in nutritional recommendations: the need for evidence based nutrition. Asia Pac. J. Clin. Nutr. 11:2002;S510-S515.
4. Clarkson T.B., Lehner N.D.M., Bullock B.C. Specialized research applications: I. Atherosclerosis research. Weisbroth S.H., Flatt R.E., Krauss A.L. The biology of the laboratory rabbit. 1974;155-165 Academic Press, San Diego.
5. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease; meta-analysis of randomised trials. Lancet. 361:2003;2017-2023.